CDC employees worried Trump may appoint anti-vaccine officials

A somber mood has taken over the Centers for Disease Control and Prevention (CDC) in Atlanta over fears of what President-elect Donald Trump may mean for the agency.

Speaking anonymously to WBAE, CDC workers described people crying in the hallways, worried about having research defunded with Trump’s promise to repeal the Affordable Care Act. One microbiologist said she’s worried Trump will appoint public health officials who oppose the idea of mandatory vaccines, like Trump allies Ben Carson, MD, or Florida Gov. Rick Scott.

Others sounded more optimistic.

“We've ran this place underfunded and we’ve done a great job,” said one CDC employee with 40 years’ experience. “With Zika, don’t forget, we were at the brink of running out of money, but we prevailed. We've got a mission, we're dedicated to it and we're going to continue it.”

For more on how the next president could affect the CDC, click on the link below: 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.